Inactivation of Cancer Mutations Utilizing CRISPR/Cas9.
Saved in:
| Title: | Inactivation of Cancer Mutations Utilizing CRISPR/Cas9. |
|---|---|
| Authors: | Gebler C; Affiliations of author: Medical Systems Biology, Medical Faculty Carl Gustav Carus, University cancer center, Technische Universitat Dresden, Dresden, Germany., Lohoff T; Affiliations of author: Medical Systems Biology, Medical Faculty Carl Gustav Carus, University cancer center, Technische Universitat Dresden, Dresden, Germany., Paszkowski-Rogacz M; Affiliations of author: Medical Systems Biology, Medical Faculty Carl Gustav Carus, University cancer center, Technische Universitat Dresden, Dresden, Germany., Mircetic J; Affiliations of author: Medical Systems Biology, Medical Faculty Carl Gustav Carus, University cancer center, Technische Universitat Dresden, Dresden, Germany., Chakraborty D; Affiliations of author: Medical Systems Biology, Medical Faculty Carl Gustav Carus, University cancer center, Technische Universitat Dresden, Dresden, Germany., Camgoz A; Affiliations of author: Medical Systems Biology, Medical Faculty Carl Gustav Carus, University cancer center, Technische Universitat Dresden, Dresden, Germany., Hamann MV; Affiliations of author: Medical Systems Biology, Medical Faculty Carl Gustav Carus, University cancer center, Technische Universitat Dresden, Dresden, Germany., Theis M; Affiliations of author: Medical Systems Biology, Medical Faculty Carl Gustav Carus, University cancer center, Technische Universitat Dresden, Dresden, Germany., Thiede C; Medical Faculty Carl Gustav Carus, Medizinische Klinik und Poliklinik I, Dresden, Germany.; German Cancer Research Center, Heidelberg and German Cancer Consortium partner site Dresden, Germany., Buchholz F; Affiliations of author: Medical Systems Biology, Medical Faculty Carl Gustav Carus, University cancer center, Technische Universitat Dresden, Dresden, Germany.; Max Planck Institute of Molecular Cell Biology and Genetics, Dresden, Germany.; German Cancer Research Center, Heidelberg and German Cancer Consortium partner site Dresden, Germany.; National Center for Tumor Diseases, University Hospital Carl Gustav Carus, TU Dresden, Dresden, Germany. |
| Source: | Journal of the National Cancer Institute [J Natl Cancer Inst] 2016 Aug 30; Vol. 109 (1). Date of Electronic Publication: 2016 Aug 30 (Print Publication: 2017). |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Oxford University Press Country of Publication: United States NLM ID: 7503089 Publication Model: Electronic-Print Cited Medium: Internet ISSN: 1460-2105 (Electronic) Linking ISSN: 00278874 NLM ISO Abbreviation: J Natl Cancer Inst Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
| FullText | Links: – Type: pdflink Text: Availability: 0 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 27576906 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Inactivation of Cancer Mutations Utilizing CRISPR/Cas9. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Gebler+C%22">Gebler C</searchLink>; Affiliations of author: Medical Systems Biology, Medical Faculty Carl Gustav Carus, University cancer center, Technische Universitat Dresden, Dresden, Germany.<br /><searchLink fieldCode="AU" term="%22Lohoff+T%22">Lohoff T</searchLink>; Affiliations of author: Medical Systems Biology, Medical Faculty Carl Gustav Carus, University cancer center, Technische Universitat Dresden, Dresden, Germany.<br /><searchLink fieldCode="AU" term="%22Paszkowski-Rogacz+M%22">Paszkowski-Rogacz M</searchLink>; Affiliations of author: Medical Systems Biology, Medical Faculty Carl Gustav Carus, University cancer center, Technische Universitat Dresden, Dresden, Germany.<br /><searchLink fieldCode="AU" term="%22Mircetic+J%22">Mircetic J</searchLink>; Affiliations of author: Medical Systems Biology, Medical Faculty Carl Gustav Carus, University cancer center, Technische Universitat Dresden, Dresden, Germany.<br /><searchLink fieldCode="AU" term="%22Chakraborty+D%22">Chakraborty D</searchLink>; Affiliations of author: Medical Systems Biology, Medical Faculty Carl Gustav Carus, University cancer center, Technische Universitat Dresden, Dresden, Germany.<br /><searchLink fieldCode="AU" term="%22Camgoz+A%22">Camgoz A</searchLink>; Affiliations of author: Medical Systems Biology, Medical Faculty Carl Gustav Carus, University cancer center, Technische Universitat Dresden, Dresden, Germany.<br /><searchLink fieldCode="AU" term="%22Hamann+MV%22">Hamann MV</searchLink>; Affiliations of author: Medical Systems Biology, Medical Faculty Carl Gustav Carus, University cancer center, Technische Universitat Dresden, Dresden, Germany.<br /><searchLink fieldCode="AU" term="%22Theis+M%22">Theis M</searchLink>; Affiliations of author: Medical Systems Biology, Medical Faculty Carl Gustav Carus, University cancer center, Technische Universitat Dresden, Dresden, Germany.<br /><searchLink fieldCode="AU" term="%22Thiede+C%22">Thiede C</searchLink>; Medical Faculty Carl Gustav Carus, Medizinische Klinik und Poliklinik I, Dresden, Germany.; German Cancer Research Center, Heidelberg and German Cancer Consortium partner site Dresden, Germany.<br /><searchLink fieldCode="AU" term="%22Buchholz+F%22">Buchholz F</searchLink>; Affiliations of author: Medical Systems Biology, Medical Faculty Carl Gustav Carus, University cancer center, Technische Universitat Dresden, Dresden, Germany.; Max Planck Institute of Molecular Cell Biology and Genetics, Dresden, Germany.; German Cancer Research Center, Heidelberg and German Cancer Consortium partner site Dresden, Germany.; National Center for Tumor Diseases, University Hospital Carl Gustav Carus, TU Dresden, Dresden, Germany. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%227503089%22">Journal of the National Cancer Institute</searchLink> [J Natl Cancer Inst] 2016 Aug 30; Vol. 109 (1). <i>Date of Electronic Publication: </i>2016 Aug 30 (<i>Print Publication: </i>2017). – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Oxford+University+Press%22">Oxford University Press </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>7503089 <i>Publication Model: </i>Electronic-Print <i>Cited Medium: </i>Internet <i>ISSN: </i>1460-2105 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2200278874%22">00278874 </searchLink><i>NLM ISO Abbreviation: </i>J Natl Cancer Inst <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=27576906 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1093/jnci/djw183 Languages: – Code: eng Text: English Titles: – TitleFull: Inactivation of Cancer Mutations Utilizing CRISPR/Cas9. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Gebler C – PersonEntity: Name: NameFull: Lohoff T – PersonEntity: Name: NameFull: Paszkowski-Rogacz M – PersonEntity: Name: NameFull: Mircetic J – PersonEntity: Name: NameFull: Chakraborty D – PersonEntity: Name: NameFull: Camgoz A – PersonEntity: Name: NameFull: Hamann MV – PersonEntity: Name: NameFull: Theis M – PersonEntity: Name: NameFull: Thiede C – PersonEntity: Name: NameFull: Buchholz F IsPartOfRelationships: – BibEntity: Dates: – D: 30 M: 08 Text: 2016 Aug 30 Type: published Y: 2016 Identifiers: – Type: issn-electronic Value: 1460-2105 Numbering: – Type: volume Value: 109 – Type: issue Value: 1 Titles: – TitleFull: Journal of the National Cancer Institute Type: main |
| ResultId | 1 |
